Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 25, 2025

Study Completion Date

December 25, 2025

Conditions
Breast CancerSentinel Lymph NodeMetastasesMargin Assessment
Interventions
DIAGNOSTIC_TEST

NIR-II Probe(i.e ICG-POL6326) incubation solution

After the tissues were incubated with the optimal concentration of the NIR-II probe for the appropriate time, the tissues were washed with the eluate, and then the fluorescence intensity of different tissues was detected to evaluate whether the tissues had cancer tissue invasion.

Trial Locations (1)

650118

RECRUITING

Yunnan Cancer Hospital, Kunming

All Listed Sponsors
collaborator

Xiang'an Hospital of Xiamen University

OTHER

lead

Yunnan Cancer Hospital

OTHER